Induction Immunotherapy (+/- Chemotherapy) in Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC)
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e674-e675
DOI: 10.1016/j.ijrobp.2026.06.2115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von L.I. El Nihum und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nihum, L. E., Lemisch, H., Cui, J., Zhang, L., Edelman, M., & Kumar, S. (2026). Induction Immunotherapy (+/- Chemotherapy) in Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics, 126(1), e674-e675. https://doi.org/10.1016/j.ijrobp.2026.06.2115
Vancouver
Nihum LE, Lemisch H, Cui J, Zhang L, Edelman M, Kumar S. Induction Immunotherapy (+/- Chemotherapy) in Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e674-e675. doi:10.1016/j.ijrobp.2026.06.2115
BibTeX
@article{Nihum2026,
author = {Nihum, L.I. El and Lemisch, H.A. and Cui, J. and Zhang, L. and Edelman, M.J. and Kumar, S.S.},
title = {Induction Immunotherapy (+/- Chemotherapy) in Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC)},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e674--e675},
doi = {10.1016/j.ijrobp.2026.06.2115}
}
EUVIMED